Theme: An Insight on Advances in Neuroscience and Neuro Infectious Diseases

Neuro infectious disorders 2017

Neuro infectious disorders 2017

OMICS International Conferences invites all the participants from all over the world to attend International Conference on Neuro Infecticious Disorders from August 28-30, 2017 Philadelphia, USA

The scientific sessions of Neuroinfection 2017 will focus on the current research areas includes Neuroinfectious Disorders, Neuroimmune interactions, its wide therapeutic aspects. There are more than 600 diseases of the nervous system, such as Alzheimer's disease, brain tumors, epilepsy, Parkinson's disease, and stroke as well as less familiar ones such as frontotemporal dementia and an estimated 6.8 million people die every year as a result of these disorders there by making it necessary to investigate the unresolved Neurological Disorder.

Track 1: Neuroinfectious Disorders

Neuroinfectious Disorders is a branch of Neuroimmunology that deals especially with the interrelationships of the nervous system and immune responses and autoimmune disorders. Its deals with particularly fundamental and applied neurobiology,neurology, neuropathology,neurochemistry, neurovirology, neuroendocrinology,neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g.immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays).

Related conference

6th Global Neurologist annual Meeting on Neurology and neurosurgery, Aug 1-3,2016, Frankfurt, Germany; 4th International conference on Neurology and therapeutics July 27-29, 2015, Rome Italy; 6th Global Neurologist annual Meeting on Neurology and neurosurgery, Aug 1-3,2016, Frankfurt, Germany; USA; 5th World Conference on Neurology and Therapeutics, March 14-16 ,2016, London UK;5th International Conference on Alzheimer’s Disease & Dementia September 29-October 01, 2016 London, UK ; 2nd Adolescent Medicine and Child Psychology Conference August 29- 31, 2016 Atlanta, USA; 3rd Euro Psychiatry Conference September 7-9, 2016 Amsterdam, Netherlands;2nd international primary immunodeficiencies congress 2015,November 5, 2015 - november 6, 2015,Budapest , budapest , hungery ; American college of allergy, asthma and immunology annual meeting 2015, November 5, 2015 - november 9, 2015,San antonio , united states;14th Transplantation science symposium 2015,November 11, 2015 - November 13, 2015,Lorne , Australia;Japanese society for immunology 44th annual meeting 2015, November 18, 2015 - November 20, 2015, Sapporo, japan; Australian society for immunology 45th annual meeting 2015, November 29, 2015 - December 3, 2015 Canberra, Australia;Turkish national allergy and clinical immunology association 22nd annual meeting 2015,November 29, 2015 - December 2, 2015,Gloria resort , bleak , Turkey;Austrian society of allergology and immunology annual symposium 2015,December 11, 2015 - December 12, 2015 Wien , Austria;8th I mmunotherapeutics & Immunomonitoring conference 2016,January 25, 2016 - January 26, 2016,San diego , ca , united states;keystone symposia: cell biology and immunology of persistent infection 2016January 31, 2016february 4, 2016,Banff , alberta , canada

Track 2:Epigenetics of Neuroinfections

This branch especially deals with the interrelationships of the nervous system and immune responses and autoimmune disorders. Its deals with particularly fundamental andapplied neurobiology,neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays).

Related conference

6th Global Neurologist annual Meeting on Neurology and neurosurgery, Aug 1-3,2016, Frankfurt, Germany; 4th International conference on Neurology and therapeutics July 27-29, 2015, Rome Italy; 6th Global Neurologist annual Meeting on Neurology and neurosurgery, Aug 1-3,2016, Frankfurt, Germany; USA; 5th World Conference on Neurology and Therapeutics, March 14-16 ,2016, London UK;5th International Conference on Alzheimer’s Disease & Dementia September 29-October 01, 2016 London, UK ; 2nd Adolescent Medicine and Child Psychology Conference August 29- 31, 2016 Atlanta, USA; 3rd Euro Psychiatry Conference September 7-9, 2016 Amsterdam, Netherlands;2nd international primary immunodeficiencies congress 2015,November 5, 2015 - november 6, 2015,Budapest , budapest , hungery ; American college of allergy, asthma and immunology annual meeting 2015, November 5, 2015 - november 9, 2015,San antonio , united states;14th Transplantation science symposium 2015,November 11, 2015 - November 13, 2015,Lorne , Australia;Japanese society for immunology 44th annual meeting 2015, November 18, 2015 - November 20, 2015, Sapporo, japan; Australian society for immunology 45th annual meeting 2015, November 29, 2015 - December 3, 2015 Canberra, Australia;Turkish national allergy and clinical immunology association 22nd annual meeting 2015,November 29, 2015 - December 2, 2015,Gloria resort , bleak , Turkey;Austrian society of allergology and immunology annual symposium 2015,December 11, 2015 - December 12, 2015 Wien , Austria;8th I mmunotherapeutics & Immunomonitoring conference 2016,January 25, 2016 - January 26, 2016,San diego , ca , united states;keystone symposia: cell biology and immunology of persistent infection 2016January 31, 2016february 4, 2016,Banff , alberta , canada

Track 3: Neuro-immune interaction

The inflammatory response is modulated through interactions among the nervous, endocrine, and immune systems. Intercommunication between immune cells and the autonomic nervous system is a growing area of interest .Spatial and temporal information about inflammatory processes is relayed to the central nervous system where neuroimmune modulation serves to control the extent and intensity of the inflammation. The CNSregulates the immune system via hormonal and neuronal pathways, including the sympathetic and parasympathetic nerves. The immune system signals the CNS through cytokines that act both centrally and peripherally.

Related conference:.

5th International Conference on Alzheimer’s Disease & Dementia September 29-October 01, 2016 London, UK ;International conference on Neurorehabitation, November 12-16, 2016, Dubai ,UAE;6th Global Neurologist annual Meeting on Neurology and neurosurgery,Aug 1-3,2016, Frankfurt, Germany;5thWorld Conference on Neurology and Therapeutics , March 14-16 ,2016, London UK; International conference on Autoimmunity , Oct 13-15, 2016, Manchester ,UK;2nd International Conference on Innate Immunity July 21-22, 2016 Berlin, Germany;4th International Conference and Exhibition on Immunology September 28-30, 2015 Houston, Texas; 5th International Conference on Immunology, Oct 24-26,2016,Chicago, USA;International Allergy Conference, Mar 2nd International Conference on Innate Immunity ,July 21st – 22nd ,2015,Berlin ,Germany; Neuroscience 2015 October 17-21 at McCormick Place in Chicago; Annual International Conference on Neuroscience and Neurobiology Research, 26-27 October, Bangkok, Thailand; International Conference on Biochemical Markers for Brain Damage,14–16 September 2015,Lund, Sweden;The 4th Champalimaud Neuroscience Symposium – Perspectives on Social Behavior ,16–19 September 2015Lisbon, Portugal; Canadian society of allergy and clinical immunology annual meeting 2015,October 21, 2015 - october 24, 2015,Ottawa , canada;Spanish society of allergy and clinical immunology 31st annual congress 2015,October 22, 2015 - October 24, 2015,Sevilla , Spain;2nd international primary immunodeficiencies congress 2015,November 5, 2015 - november 6, 2015,Budapest , budapest , hungery ; American college of allergy, asthma and immunology annual meeting 2015, November 5, 2015 - november 9, 2015,San antonio , united states;14th Transplantation science symposium 2015,November 11, 2015 - November 13, 2015,Lorne , Australia;Japanese society for immunology 44th annual meeting 2015, November 18, 2015 - November 20, 2015, Sapporo, japan; Australian society for immunology 45th annual meeting 2015, November 29, 2015 - December 3, 2015 Canberra, Australia;Turkish national allergy and clinical immunology association 22nd annual meeting 2015 

Track 4: Neuroimmunological infectious diseases

The term neuro-immune disease refers to a group of complex multisymptom diseases characterized by acquired deregulation of both the immune system and the nervous system. These diseases most often follow an infectious or flu-like illness and may result in lifelong disease and disability. Encephalitis is defined as inflammation of the brain. This definition means encephalitis is different from meningitis, .Multiple sclerosis also a big example of Neuroimmunological Infectious disease

Related Conference

International conference on Autoimmunity , Oct 13-15, 2016, Manchester ,UK;4th International conference and Exhibition on immunology September 28-30, 2015, Houston USA;5th International Conference on Immunology October 24-26,2015 Chicago , USA;International conference on Neurorehabitation, November 12-16, 2016, Dubai ,UAE;6th Genomics and Pharmacogenomics Conference; September 22-24, 2016 Berlin, Germany; 5th International Conference on Immunology October 24-26, 2016 Chicago, USA;4th International Conference and Exhibition on Immunology September 28-30, 2015 Houston, USA; 8th Indo Global summit and Expo on Vaccines, Therapeutics & Healthcare November 02-04, 2015 HICC, Hyderabad, India; International Conference on Hepatitis Vaccines June 16-18, 2016 Rome, Italy; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; Conference for Young Scientists 2015 (CYS-2015)21–25 September 2015 Kyiv, Ukraine;Neuroscience 2015 October 17-21 at McCormick Place in Chicago; Annual International Conference on Neuroscience and Neurobiology Research, 26-27 October, Bangkok, Thailand 

Track 5: Neurovirology

The term neurovirology refers to a group of complex multisymptom diseases characterized by acquired deregulation of both the immune system and the nervous system. These diseases most often follow an infectious or flu-like illness and may result in lifelong disease and disability. Encephalitis is defined as inflammation of the brain. This definition means encephalitis is different from meningitis, .Multiple sclerosis also a big example of Neuroimmunological Infectious disease

Related conference

4th International Conference and Exhibition on Immunology September 28-30, 2015 Houston, USA;8th Indo Global summit and Expo on Vaccines, Therapeutics & Healthcare November 02-04, 2015 HICC, Hyderabad, India; International Conference on Cancer Immunology and Immunotherapy July 28-30,2016 Melbourne, Australia;2nd International Conference and Exhibition on Antibodies July 14-15, 2016 Philadelphia, US;International Allergy Conference March 29-30, 2016 Valencia, Spain;2nd International Conference on ‘Brain disorder and therapeutics , October 27-29,2016, Chicago, USA;2nd International Conference on Neurological Disorder and Stroke , April 28-30, 2016, Dubai, UAE; 2nd International Conference on Parasitology August 01-03, 2016 Manchester, UK; Global Neuroscience conference , Nov 7-9, 2016, Melbourne , Australia ;4th International Conference on Vascular Dementia ,June 30- July 2, 2016, Valencia , Spain; 2nd International Conference on Parasitology August 01-03, 2016 Manchester, UK;International Conference on Hepatitis Vaccines June 16-18, 2016 Rome, Italy;5th International Conference on Immunology October 24-26, 2016 Chicago, USA; The Lancet NeurologyAutoimmune Disorders Conference, March 26-27, 2015 Barcelona, Spain; 10th International Conference on Front temporal Dementias 31 August - 2 September 2016 Munich, Germany; European Neurology conference , Sep 10-12, Amsterdam, Netherland ; 6thworld Neurological conference, May 19-21, 2016, San Atlanto,USA; International conference on Neurogenetics, June 6-7, London,UK; Neuroscience 2015 October 17-21 at McCormick Place in Chicago; Annual International Conference on Neuroscience and Neurobiology Research, 26-27 October, Bangkok, Thailand; The 4th Champalimaud Neuroscience Symposium – Perspectives on Social Behavior; Canadian society of allergy and clinical immunology annual meeting 2015,October 21, 2015 - october 24, 2015,Ottawa , canada;Spanish society of allergy and clinical immunology 31st annual congress 2015,October 22, 2015 - October 24, 2015,Sevilla , Spain 

Track 6: Autoimmune Neuropathies

Neuropathology and  Neurobiology is a peer-reviewed medical journal in the field of neuropathology. It is published by Wiley-Blackwell for the British Neuropathological Society. The journal was established in 1974 and is published bimonthly. Neurobiology is the branch of biology that deals with nervous system functions and structures. More specifically, neurobiology focuses on the cells and tissues of the nervous system and how they can form structures and circuits (pathways) for controlling the body. This system includes common structures, such as the brain and spinal cord, and nerves. Neurobiology can be classified as a sub-discipline within the broader field of physiology.

Related conference

 Neurology conference 16–19 September 2015 Lisbon, Portugal; International Conference on Biochemical Markers for Brain Damage, 14–16 September 2015,Lund, Sweden; International Conference on Cancer Immunology and immunotherapy , July 28th to 30th, 2015, Melbourne , Australia; 6th Global Neurologist annual Meeting on Neurology and neurosurgery, Aug 1-3,2016, Frankfurt, Germany; USA; 5th World Conference on Neurology and Therapeutics , March 14-16 ,2016, London UK; International Conference on Hepatitis Vaccines June 16-18, 2016 Rome, Italy; International Conference on Cancer Immunology and Immunotherapy July 28-30,2016 Melbourne, Australia; 4th International Conference and Exhibition on Immunology September 28-30, 2015 Houston, USA;8th Indo Global summit and Expo on Vaccines, Therapeutics & Healthcare November 02-04, 2015 HICC, Hyderabad, India; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia;European Neurology conference , Sep 10-12, Amsterdam, Netherland ; 6thworld Neurological conference, May 19-21, 2016, San Atlanto,USA; International conference on Neurogenetics, June 6-7, London,UK; Neuroscience 2015 October 17-21 at McCormick Place in Chicago; Annual International Conference on Neuroscience and Neurobiology Research, 26-27 October, Bangkok, Thailand; The 4th Champalimaud Neuroscience Symposium – Perspectives on Social Behavior.

Track 7: Neuroinflammation

Allergy may be a kind of disorder of system that is susceptible in nature. Some quite common symptoms of allergic reaction are haptic sensation, running nose, continuous unconditioned reflex, eczema, red eyes etc. once the system of our body reacts with any harmless substances (allergens) within the atmosphere, it causes allergic reaction. The medicines of allergic reaction are in the main obtainable in type of inhalers, eye drops, skin creams, injections, pills, nasal sprays and liquids. Most of the medicines for allergic reaction are obtainable by prescription however few of them are obtainable over counters. Whenever our body is to associate degree matter it triggers your system. Hence antihistamines stop these symptoms by obstruction aminoalkane and keeping it from binding to receptors.

Related Conference

5th International Conference on Immunology October 24-26, 2016 Chicago, USA;4th International Conference and Exhibition on Immunology September 28-30, 2015 Houston, USA; 8th Indo Global summit and Expo on Vaccines, Therapeutics & Healthcare November 02-04, 2015 HICC, Hyderabad, India; International Conference on Hepatitis Vaccines June 16-18, 2016 Rome, Italy; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; 4th International Conference and Exhibition on Immunology September 28-30, 2015 Houston, USA;8th Indo Global summit and Expo on Vaccines, Therapeutics & Healthcare November 02-04, 2015 HICC, Hyderabad, India; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; 2nd International Conference and Exhibition on Antibodies July 14-15,2016 Philadelphia, US;International Allergy Conference March 29-30, 2016 Valencia, Spain;4th Venusberg Meeting on Neuroinflammation 7th May 2015 at 09:00 - 9th May 2015 at 16:30,Berlin; Neuroinflammation Is disease of CNS, January 25—30, 2015Sagebrush Inn & Suites Taos, New Mexico USA 12th world congress on Neuroinflammation Aug 8-12, 2015, Boston, Massachusetts, USA; FENS Forum of Neuroscience, July 2-6 2016, Europe; AAPS Annual Meeting, November 12-16 2016, USA; Schizophrenia International Research Society Conference,April 2-6,2016 Italy; International Conference on Biochemical Markers for Brain Damage,14–16 September 2015,Lund, Sweden; Canadian society of allergy and clinical immunology annual meeting 2015,October 21, 2015 - october 24, 2015,Ottawa , canada;Spanish society of allergy and clinical immunology 31st annual congress 2015,October 22, 2015 - October 24, 2015,Sevilla , Spain. 

Track:8 Clinical Neuroimmunology

Multiple Sclerosis and Related Disorders serves as an indispensable resource for physicians interested in, and dealing with, this very complex and evolving branch of neurology. This comprehensive title provides an introduction to basic neuroimmunology and principles of immunotherapy and also serves as a thorough guide to immune-mediated disorders of the central and peripheral nervous system, as well as other systemic disorders with a significant neuroimmunologic component.

Related conference:

 4th International conference & Exhibition on Neurology and Therapeutics July 27-29, 2015 Rome, Italy;5th World Congress on Neurology and Therapeutics March 14-16, 2016 London, UK ;nternational Conference on Neuro Genetics June 06-07, 2016 London, UK; 6th World Neurological Conference May 19-21, 2016 San Antonio, USA; 5th International Conference on Alzheimer’s Disease & Dementia September 29-October 01, 2016 London, UK ; 6thGlobal Neurologist annual Meeting on Neurology and neurosurgery,Aug 1-3,2016, Frankfurt, Germany; 4th International conference on Neurology and therapeutics July 27-29, 2015, Rome Italy; canada;Spanish society of allergy and clinical immunology 31st annual congress 2015,October 22, 2015 - October 24, 2015,Sevilla , Spain; Gloria resort , bleak , Turkey;Austrian society of allergology and immunology annual symposium 2015,December 11, 2015 - December 12, 2015 Wien , Austria;8th I mmunotherapeutics & Immunomonitoring conference 2016,January 25, 2016 - January 26, 2016,San diego , ca , united states;Allergy Conferences September 14-15, 2016 Amsterdam, Netherlands;Asthma Events September 14-15, 2016 Amsterdam, Netherlands;

Track 9: Blood Brain Barrier

More than 100 years ago it was discovered that if blue dye was injected into the bloodstream of an animal, that tissues of the whole body except the brain and spinal cord would turn blue. To explain this, scientists thought that a "Blood-Brain-Barrier" (BBB) which prevents materials from the blood from entering the brain existed. The BBB is semi-permeable; that is, it allows some materials to cross, but prevents others from crossing. In most parts of the body, the smallest blood vessels, called capillaries, are lined with endothelial cells. Endothelial tissue has small spaces between each individual cell so substances can move readily between the inside and the outside of the vessel. However, in the brain, the endothelial cells fit tightly together and substances cannot pass out of the bloodstream.

Related conference

2nd International Conference on ‘Brain disorder and therapeutics , October 27-29,2016, Chicago, USA;2nd International Conference on Neurological Disorder and Stroke , April 28-30, 2016, Dubai, UAE; 2nd International Conference on Parasitology August 01-03, 2016 Manchester, UK; Global Neuroscience conference , Nov 7-9, 2016, Melbourne , Australia ;5th Neurology Congress March 14-16, 2016 London, UK; 5th Alzheimer’s disease and Dementia Conference September 29-Oct 1, 2016 London, UK;2nd Brain Disorders Conference October 27-29, 2016 Chicago, USA;2nd Neurological Disorders and Stroke Conference April 28-30, 2016 Dubai, UAE; 4th Vascular Dementia ConferenceJune 30-July 2, 2016 Valencia, Spain; 4th International Conference on Vascular Dementia ,June 30- July 2, 2016, Valencia , Spain; Barriers of the CNS, Gordon Research Conference June 17-22, 2012 Colby-Sawyer College New London, NH; Blood Brain Barrier(BBB) Meeting March 3-5, 2016, Skamania Lodge, Stevenson, WA; Blood Brain Barrier congress, June 10-11, 2015, westin Boston Waterfront, Boston, MA; 2nd International Conference on Innate Immunity July 21-22, 2016 Berlin, Germany; International Conference on Hepatitis Vaccines June 16-18, 2016 Rome, Italy; BioMed Conference, Blood Brain Barrier, 2 Nov 2015 to 4 Nov 2015, Barcelona; Canadian society of allergy and clinical immunology annual meeting 2015,October 21, 2015 - october 24, 2015,Ottawa , canada;Spanish society of allergy and clinical immunology 31st annual congress 2015,October 22, 2015 - October 24, 2015,Sevilla , Spain;2nd international primary immunodeficiencies congress 2015,November 5, 2015 - november 6, 2015,Budapest , budapest , hungery ; American college of allergy, asthma and immunology annual meeting 2015, November 5, 2015 - november 9, 2015,San antonio , united states;14th Transplantation science symposium 2015,November 11, 2015 - November 13, 2015,Lorne , Australia;Japanese society for immunology 44th annual meeting 2015, November 18, 2015 - November 20, 2015, Sapporo, japan. 

Track 10: Neuropharmacology

Neuropharmacology means the study of drug affect on the cellular function in the nervous system. Behavioral neuropharmacology and molecular neuropharmacology are the two main branches. Behavioral neuropharmacology focus on the study of drugs affect on human behavior (neuropsychopharmacology), including the study of drug dependence and addiction affect on the human brain. Molecular neuropharmacology is the study of neurons and their neurochemical interactions, with the objective of developing drugs that have beneficial effects on neurological function

Related conference

3rd World Congress on Pharmacology, August 08-10 2016, UK; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 07-09 2016, Spain; European Neurology Congress September 10-12 2016, Amsterdam; Society for Neuroscience Annual Meeting, November 12-16 2016, USA; Stress And Behavior Neuroscience and Biopsychiatry Conference, May 16-19 2016,Russia;International conference on Autoimmunity , Oct 13-15, 2016, Manchester ,UK;4th International conference and Exhibition on immunology September 28-30, 2015, Houston USA;5th International Conference on Immunology October 24-26,2015 Chicago , USA;International conference on Neurorehabitation, November 12-16, 2016, Dubai ,UAE;6th Genomics and Pharmacogenomics Conference; September 22-24, 2016 Berlin, Germany; FENS Forum of Neuroscience, July 2-6 2016, Europe; AAPS Annual Meeting, November 12-16 2016, USA; Schizophrenia International Research Society Conference,April 2-6,2016 Italy; International Conference on Biochemical Markers for Brain Damage,14–16 September 2015,Lund, Sweden;4th International Conference on Vascular Dementia ,June 30- July 2, 2016, Valencia , Spain; Barriers of the CNS, Gordon Research Conference June 17-22, 2012 Colby-Sawyer College New London, NH; Blood Brain Barrier(BBB) Meeting March 3-5, 2016, Skamania Lodge, Stevenson, WA; Blood Brain Barrier congress, June 10-11, 2015, westin Boston Waterfront, Boston, MA; 2nd International Conference on Innate Immunity July 21-22, 2016 Berlin, Germany; International Conference on Hepatitis Vaccines June 16-18, 2016 Rome, Italy; BioMed Conference, Blood Brain Barrier, 2 Nov 2015 to 4 Nov 2015, Barcelona; Canadian society of allergy and clinical immunology annual meeting 2015,October 21, 2015 - october 24, 2015,Ottawa , canada;Spanish society of allergy and clinical immunology 31st annual congress 2015,October 22, 2015 - October 24, 2015,Sevilla , Spain.

Track 11: Antibody mediated disorder

In antibody-mediated inflammatory disease, B cells produce antibodies against the body's own structures; these are called auto-antibodies. When auto-antibodies bind to these structures, they induce unnecessary inflammation that is directed against healthy tissue. Autoantibodies directed against structures in the brain lead to irritation and swelling of brain tissue. If not treated, long standing inflammation can lead to permanent brain damage and dysfunction.

Related conference:

Antibiotics Conference September 14-16, 2015 Las Vegas, USA;2nd Antibodies Conference July 14-15, 2016 Philadelphia, USA;5th Immunology Conference Oct 24-26, 2016 Chicago, USA;European Immunology Conference July 21-23, 2016 Berlin, Germany; 2ndInnate Immunity Conference July 21-22, 2016 Berlin, Germany;Autoimmunity Conference Oct 13-15, 2016 Manchester, UK ;4th International conference & Exhibition on Neurology and Therapeutics July 27-29, 2015 Rome, Italy; 5th World Congress on Neurology and Therapeutics March 14-16, 2016 London, UK ;International Conference on Neuro Genetics June 06-07, 2016 London, UK; 6th World Neurological Conference May 19-21, 2016 San Antonio, USA; 5th International Conference on Alzheimer’s Disease & Dementia September 29-October 01, 2016 London, UK ;Mucosal Immunology Conference July 28-29, 2016, Melbourne, Australia; Cancer Immunology and ImmunotherapyConference uly 28-30, 2016, Melbourne, Australia BIT's 7th Annual International Congress of Antibodies-2015 April 25-28, 2015 Nanjing, China ;15th International Congress on Anti-phospholipid Antibodies , Sep 21-24 ,2016,Istanbul, Turkey.5th International Conference on Immunology October 24-26, 2016 Chicago, USA; The Lancet Neurology Autoimmune Disorders Conference, March 26-27, 2015 Barcelona, Spain; 10th International Conference on Front temporal Dementias 31 August - 2 September 2016 Munich, Germany; 12th Global Vaccine and Vaccination Submit and Expo, Oct 20th -22nd 2016,Dubai, UAE; World Congress and Exhibition on Antibodies ,Sep 14th – 16th . Las Vegas, Nevada. USA; 2nd International Conference on Innate Immunity, July 21st – 22nd ,2015,Berlin ,Germany; Canadian society of allergy and clinical immunology annual meeting 2015,October 21, 2015 - october 24, 2015,Ottawa , canada;Spanish society of allergy and clinical immunology 31st annual congress 2015,October 22, 2015 - October 24, 2015,Sevilla , Spain. 

 

 

OMICS International Conferences invites all the participants from all over the world to attend International Conference on Neuro Infecticious Disorders from August 28-30, 2017 Philadelphia, USA

The scientific sessions of Neuroinfection 2017 will focus on the current research areas includes Neuroinfectious disorders, Neuroimmune interactions, its wide therapeutic aspects. There are more than 600 diseases of the nervous system, such as Alzheimer's disease, brain tumors, epilepsy, Parkinson's disease, and stroke as well as less familiar ones such as frontotemporal dementia and an estimated 6.8 million people die every year as a result of these disorders there by making it necessary to investigate the unresolved Neurological Disorder.

Why to attend???

With members from around the world focused on learning about Neuroinfectious diseases and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neuropharmacology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neuropharmacology are hallmarks of this conference.

Target Audience:

Neuroimmunology  Students, Scientists

Neuroimmunology Researchers

Neuroimmunology Faculty

Medical Colleges

Psychiatrists

Neuroimmunology Associations and Societies

Business Entrepreneurs

Training Institutes

Software developing companies

Manufacturing Medical Devices Companies

Data Management Companies

 

Summary:

Neuroinfection 2017 welcomes attendees, presenters, and exhibitors from all over the world to Philadelphia, USA. We are delighted to invite you all to attend and register for the “International Conference onNeuro Infecticious Disorders” which is going to be held during August 28-30, 2017, Philadelphia, USA. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuroinfection 2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Neuroinfection 2017 organizing committee look forward to meet you at Atlanta, USA.

For more details please visit: http://neuroinfection.conferenceseries.com/

 

Importance and Scope:

The nervous and immune systems are in constant dialogue, but details of how these two essential systems are integrated and functionally cooperate at the molecular level are only now being revealed. Much of the recent research in this area has focused on the role of immune cells and immune mediators in the initiation and progression of specific neurological diseases, such as multiple sclerosis and Alzheimer's disease. But how do autoimmune T cells get into the brain and how do they contribute to neurological diseases? Is microglial cell activation in the brain neurodestructive or neuroprotective? Can serum antibodies affect brain function? What are the functional contributions of genetic determinants to multiple sclerosis susceptibility? These and other questions have important implications for the treatment of neurological disorders with an inflammatory component.

Why Philadelphia, USA?

The global market for drugs used in mental disorders was $70.1 billion in 2012 and $68.9 billion in 2013. This market is expected to rise at a compound annual growth rate (CAGR) of 2.3% from 2013 to 2018 and reach $77.1 billion by 2018. The United States is the world’s largest market for pharmaceuticals and the world leader in biopharmaceutical research. The biopharmaceutical pipeline also has over 5,000 new medicines currently in development around the world with approximately 3,400 compounds currently being studied in the United States. San Antonio itself is a home of many pharmaceutical companies such as BioNumerik Pharmaceuticals, Evestra, Genemed synthesis, GenSpera, Genzyme, Ockham Development Group, Radiant Research, SRI International and universities like University of Texas. San Antonio is also a famous tourist destination. The major attraction includes Spanish colonial missions, the Alamo, the River Walk, the Tower of the Americas, the Alamo Bowl, and Marriage Island.

Conference Highlight

·         Inflammatory diseases and therapeutics

·         Neuroendocrine cell and current research

·         Neuroimmune cross-talk

·         Meningitis

·         Neuro-immune interaction

·         Pathogenesis of immune-mediated neurological disorders

·         Auto immune neuropathies discussion

·         Rheumatoid arthritis

·         Self-killer immune system

·         Leukoencephalopathies

·         Fundamental Immunology

·         Pediatrics Autoimmune disorder

·         Applied Neurobiology

·         Neurocystercercosis

·         Schizophrenia

·         Premature aging

·         Relaxation therapies                              

Hospitals associated with Neuroinfectious diseases

Top Hospitals in USA

·         Mayo Clinic, Rochester, Minnesota

·         Johns Hopkins Hospital, Baltimore, Maryland

·         Massachusetts General Hospital, Boston

·         University of California–San Francisco Medical Center

·         Mathodist Hospital, San Antonio

·         University of California–Los Angeles Medical Center

·         New York University Langone Medical Center, New York City

·         Hospitals of the University of Pennsylvania–Penn Presbyterian

·         Northwestern Memorial Hospital, Chicago

·         Baptist Medical Centre, San Antonio

 

Major Neuroinfections related Associations around the Globe

·  Malaysian Society Of Neurosciences

·  ÄŒeská Neurologická Společnost

·  The Czech Neuropsychopharmacological Society

·  European Academy Of Neurology

·  Deutsche Gesellschaft Fur Neurologieologie

·  International Brain Research Organization

·  The Neuropathy Association

·  The Primary Care Neurology Society

·  The Spanish Society Of Neurology (SEN)

·  Euro pean Parkinson’s disease Association

·  Malaysian Society of Neurosciences

·  Eurospine, The Spine Society Of Europe

·  The Spanish Society of Neurology (SEN)

·  The Czech Neuropsychopharmacological Society

·  Belgian Neurological Society

·  National Neurotrauma Society

·  National Parkinson'S Foundation

·  European Society Of Neurosonology And Cerebral Hemodynamics

·  Federation Of European Neuroscience Societies

·  Canadian Neurological Sciences Federation

 

Major Neuropharmacology related Associations in USA

·  National Institute Of Environmental Health Sciences

·  The American Society of Neuroimaging

·  American Board Of Psychiatry And Neurology, Inc.

·  American Clinical Neurophysiology Society

·  International Neuropsychological Society

·   Society For Neuroscience

·  American Psychological Association

·  International Parkinson and Movement Disorder Society

·  American Neurological Association

·  Southern Clinical Neurological Society

·  International Parkinson And Movement Disorder Society

·  International Neuroethics Society

·  Society for Behavioral Neuroendocrinology

 

Universities in USA

·  Stanford University

·  University of North Carolina—​Chapel Hill

·  University of Minnesota

·  University of Kentucky

·  University of Washington

·  University of Texas

·  University of California

·  University of Maryland

·  Trinity University

·  Texas Southern University

·  University of Houston

Products for Neurological Treatment

This above statistic displays the global revenue of Abilify from Bristol-Myers Squibb from 2011 to 2014. In the United States alone, Abilify generated a revenue of 2.1 million U.S. dollars in 2012. Abilify is an antipsychotic agent that is used to treat various conditions such as schizophrenia, bipolar mania disorder, and major depressive disorder.

Gross Profit Margin of Neuroinfections related companies

 

Market Capitalization of Neuroimmunological companies: In 2014, investors provided $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric illnesses. Some big drug companies, including Johnson & Johnson, Roche and Novartis, are finding ways to reinvigorate their efforts. New medicines for severe depression, psychosis and schizophrenia could reach the market within the next few years, and treatments for Alzheimer’s, Parkinson’s and some forms of autism are a real possibility, too.

Institutes funding for research

1)     IMSF – Institute for Multiple Sclerosis Research in Göttingen

2)    Neuroimmunology Program, The National Institute of Mental Health (NIMH)

3)      McKnight Endowment Fund for Neuroscience

The statistic depicts the research and development expenditure of the entire pharmaceutical industry of the United States from 1995 to 2014. In 2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars.

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 28-30, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View